Amgen

Merck's Big Vytorin Study Could Pose A Challenge For Amgen, Sanofi, And Regeneron, Too
Forbes
Fri, 03/8/13 - 11:04 am
Merck
Vytorin
Regeneron
Sanofi
Amgen
Merck names ex-Amgen exec to run R&D
Yahoo/AP
Fri, 03/8/13 - 10:02 am
Merck
Amgen
R&D
Roger Perlmutter
Amgen Benefits From Affymax Recall
Seeking Alpha
Tue, 03/5/13 - 11:58 am
Amgen
Affymax
recalls
Omontys
Takeda
kidney disease
FDA halts pediatric study of Amgen's Sensipar after death
Fierce Pharma
Fri, 03/1/13 - 12:00 pm
Sensipar
Amgen
FDA
clinical trials
hyperparathyroidism
US Supreme Court rules against Amgen in class action
Reuters
Wed, 02/27/13 - 12:26 pm
Amgen
Supreme Court
Can JAK Inhibitors Challenge Biologics?
Motley Fool
Wed, 02/20/13 - 05:15 pm
JAK inhibitors
Remicade
JNJ
Enbrel
Stelara
Amgen
Humira
AbbVie
Amgen's Future Is Brighter Than You Might Think
Motley Fool
Tue, 02/19/13 - 10:13 am
Amgen
China Biotech In Review: Amgen To Build China Presence With Partnerships / M&A
Seeking Alpha
Sun, 02/17/13 - 12:07 pm
M&A
Shenghuo Pharmaceutical Holdings
Shanshi Medical Device
Amgen
OxOnc Development
Celgene
Does the Arthritis Market Have Growing Pains?
Motley Fool
Sun, 02/17/13 - 11:51 am
rheumatoid arthritis
AbbVie
Pfizer
Merck
JNJ
Amgen
Amgen Inc: Today's Featured Drugs Laggard
The Street
Sat, 02/16/13 - 11:25 am
Amgen
Amgen, UCB halt testing of drug for fracture healing, but continue testing for osteoporosis
Yahoo/AP
Tue, 02/12/13 - 10:55 am
Amgen
UCB Pharmaceuticals
fractures
osteoporosis
romosozumab
Analysis: Amgen fighting on both sides of the biosimilars battle
Fierce Biotech
Fri, 02/8/13 - 12:05 pm
Amgen
biosimilars
Amgen outlines pipeline, sees push into biosimilars
Reuters
Thu, 02/7/13 - 10:04 am
Amgen
biosimilars
What Will Type 2 Diabetes Treatments Look Like in 5 Years?
Motley Fool
Wed, 02/6/13 - 08:34 am
diabetes
Merck
SGLT2 inhibitor
Bristol-Myers Squibb
AstraZeneca
JNJ
Array Biopharma
Januvia
Amgen
Forixga
GKAs
Amgen's Neulasta Succeeds in Phase 3 Cancer Trial
Motley Fool
Mon, 01/28/13 - 12:29 pm
Amgen
Neulasta
colorectal cancer
Statins Beware?
Motley Fool
Mon, 01/28/13 - 12:21 pm
statins
PCSK9 inhibitors
Sanofi
Amgen
Pfizer
Roche
Regeneron
Can Biologics Make You Rich?
Motley Fool
Sun, 01/27/13 - 11:21 am
AbbVie
Amgen
Biogen Idec
JNJ
Roche
Bristol-Myers Squibb and 3 Top Pharma Stocks with Earnings Investors Must See
Wall Street Cheat Street
Sun, 01/27/13 - 11:09 am
Bristol-Myers Squibb
earnings
Amgen
Celgene Corporation
AmerisourceBergen
Amgen Announces Results From Phase 3 PAVES Study Evaluating Neulasta In Patients With Colorectal Cancer
Yahoo/PR Newswire
Sat, 01/26/13 - 11:52 am
Amgen
Neulasta
colorectal cancer
colon cancer
It's All Relative for This Biotech Underperformer
Motley Fool
Sat, 01/26/13 - 11:47 am
Amgen
Celgene Corporation

Pages